Recent Finacing
Recent Raise
BenevolentAI operates an AI "brain" platform ingesting billions of cross‑domain data points to accelerate drug discovery, including clinical‑stage Parkinson's and ALS programs, and to apply to materials and energy.
Focus Areas
Recent Investors
Valuation as of 04/18/2018
Total Raised
Funding round
Investor
See the team members at BenevolentAI.
